Introduction
Experimental mouse scrapie is one of the best understood of the subacute spongiform encephalopathies, which affect humans and animals (Lampert et al., 1972; Brown, 1990; Collee, 1990) . The exact nature of the scrapie agent remains unknown, but several hypotheses have been put forward, including retrovirus (Murdoch et al., 1990) , virino (Kimberlin, 1982) , prion (Prusiner, 1991) , holoprion (Weissmann, 1991) or post-translational disease involving protein synthesis dysregulation (Bolton & Bendheim, 1988) . Most studies of scrapie pathogenesis have been performed after experimental infection of laboratory rodents at the adult stage, when the brain is mature. Thus, the effect of scrapie inoculation on the developing brain, particularly during astrocyte proliferation, and neuronal and glial cell differentiation, remains to be determined. Cases of Creutzfeldt-Jakob disease that have occurred in young children (less than 12 years old) treated with growth hormone extracted from pituitary glands (Billette de Villemeur et al., 1991) indicate that the study of scrapie infection in developing and maturing brain is of interest. We have chosen to focus on the newborn mouse scrapie infection model.
The prion protein (PrP) and the glial fibrillary acidic protein (GFAP) are the two major components which accumulate in brain during spongiform encephalopathies (Prusiner, 1991; Dormont et al., 1981) . The GFAP (40K to 54K) is the major subunit of astrocyte intermediate filaments (Malloch et al., 1987) . The increase in GFAP gene expression in scrapie-infected animals is consistent, and seems to be more important than in other diseases of the brain (Manuelidis et al., 1987) . PrP (33K to 35K) is a membrane-bound sialoglycoprotein associated mainly with neurons (Stahl et al., 1987) . Its function in brain is unknown. Two different isoforms of PrP co-exist in scrapie-infected brains, PrP c (cellular) and PrP sc (scrapie), which is a proteaseresistant form. PrP sc appears to differ from its cellular isoform owing to post-translational modification (Prusiner, 1991) . Whereas the amount of GFAP mRNA increases during the development of scrapie (Lazarini et al., 1991) , that of PrP mRNA remains constant in both scrapie-infected and uninfected mouse brain (Chesebro et al., 1985) . Interestingly, both PrP and GFAP mRNAs have been found to be regulated throughout development (Lieberburg, 1987; Mobley et al., 1988; Tardy et al., 1989) . PrP gene expression increases fourfold between birth and adulthood (Lazarini et al., 1991) . Thus, it was of interest to determine whether PrP mRNA levels, which might be regulated by endogenous nerve growth factor (Mobley et al., 1988) , are modified in the brain during the development of scrapie in mice infected as neonates. We also examined the scrapie-induced increase in GFAP mRNA in scrapie-inoculated newborn mice. R N A preparation and Northern blot analysis. At regular intervals during brain development (days 1, 7, 14, 21, 28, 42, 49 and 56) and scrapie incubation (days 84, 112, 140 and 172), mice were killed by cervical column dislocation, and their brains were dissected, frozen directly in liquid nitrogen and kept at -8 0 °C until use. RNA was isolated from whole brain and electrophoresed as described previously (Chomczynski & Sacchi, 1987; Lazarini et al., 1991) . Both scrapie and control brain preparations yielded 1 to 2 mg of total RNA/g of wet tissue. All experiments were performed in triplicate. Probes were labelled to high specific activity with [~t-32p]dCTP (110 MBq/mmol, Amersham) by nick translation (Bethesda Research Laboratories), and hybridization was performed at 42 °C in 50~ (v/v) formamide, 5 x SPE (1 x SPE is 180 mM-NaCI, 10 mM-Na2HPOa, 1 mM EDTA pH 7-4), 5 x Denhardt's solution, 50 pg/ml denatured salmon sperm D N A (Boehringer) and 0.5~ SDS.
Methods

Inoculation
The probes used were (i) the rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene cloned as a 1270 nucleotide cDNA in pBR322 (Fort et al., 1985) , kindly provided by Dr P. Fort (Universit6 de Montpellier, France), (ii) the mouse fl-actin gene cloned as a 1150 nucleotide cDNA in the plasmid PAL41 (Alonso et al., 1986) , kindly provided by Dr S. Alonso (Institut Pasteur, Paris, France), (iii) the mouse GFAP gene (Lewis et al., 1984) , extracted from the pUC plasmid kindly provided by Dr N. J. Cowan (New York University, N.Y., U.S.A.) as a 1100 nucleotide HindllI fragment, and (iv) the hamster PrP gene (Basler et al., 1986) cloned as a 1800 nucleotide HindlII hamster cDNA (plasmid kindly provided by Dr D. Westaway, University of California, San Francisco, Ca., U.S.A.).
Filters were washed twice with 1 x SPE, 0-1 ~ SDS for 5 min at room temperature and twice with 0.1 x SPE, 0.1~ SDS for 10 min at 42 °C before autoradiography. Autoradiographic signals were quantified using an LKB laser densitometer (2202 Ultroscan, LKB Bromma).
Results and Discussion
In our mouse scrapie model, we observed, as did Hotchin & Buckley (1977) , that survival after intracerebral inoculation at birth is in the same range as when the inoculation is performed during adulthood (56 days), i.e. 173 + 5 days for inoculated newborn mice and 182 + 4 days for adults. The onset of the clinical stage is at approximately 160 days. Quantitative kinetics for both the PrP and GFAP mRNAs were established by Northern blot analysis throughout the course of the disease in the brains of mice inoculated at birth with the scrapie agent. We used fl-actin and GAPDH gene expression as internal controls for all Northern blots.
Regulation of PrP gene expression in scrapie-infected newborn mice
During cerebral development (1 to 56 days), the level of PrP mRNA (2.5 kb) in the brains of 56-day-old mice became threefold that in 1-day-old animals. The increase in the level of m R N A seems to be linear throughout brain development. No difference in the expression of the PrP gene in scrapie-inoculated and control animals ( Fig. 1 and 2a ) was detected during development or adulthood. It is interesting to note that although PrP m R N A levels were low in the first days of life, the survival times of mice inoculated at birth (173 + 5 days) and animals infected as adults (182 + 4 days) are similar. Therefore the amount of PrP m R N A , and probably that of PrP ¢, in the cell, is not a limiting factor in the initial events of scrapie infection.
Regulation of GFAP gene expression in scrapie-infected newborn mice
The amount of murine G F A P m R N A (2-7 kb) increased twofold between 1 and 14 days after inoculation (astrocyte proliferation), then declined slightly, which might reflect astrocyte cell differentiation; this was observed until adulthood. Northern blots revealed that scrapie-infected and control mouse brains did not exhibit any difference in G F A P m R N A levels during the developmental phase ( Fig. 1 and 2b) . However, in infected animals we found that whereas PrP,/~-actin and G A P D H m R N A levels remained constant, G F A P m R N A s increased significantly as early as 84 days postinoculation and had increased 10-fold by day 112; this level was maintained until death, which occurred at day 172 ( Fig. 3 and 4) .
In conclusion, the studies reported here reveal that (i) PrP, G F A P and /~-actin gene expression is highly regulated in the development of the murine central nervous system, (ii) inoculation of scrapie agent into newborn mice does not induce any specific change in these gene expression patterns in developing brain (0 to 56 days) and (iii) a significant increase in G F A P m R N A 
